Filing Details
- Accession Number:
- 0001364099-10-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-19 12:00:00
- Reporting Period:
- 2010-01-14
- Filing Date:
- 2010-01-19
- Accepted Time:
- 2010-01-19 13:34:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1364099 | Innophos Holdings Inc. | IPHS | Wholesale-Chemicals & Allied Products (5160) | 201380758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1379626 | Randy Gress | 259 Prospect Plains Road Cranbury NJ 08512 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-14 | 20,000 | $2.55 | 144,158 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-15 | 20,000 | $21.88 | 124,158 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock | Disposition | 2010-01-14 | 20,000 | $2.55 | 20,000 | $2.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
233,528 | 2015-04-15 | No | 4 | M | Direct |
Footnotes
- Transactions carried out by the reporting person pursuant to a plan established on June 15, 2009 under Rule 10b5-1 for the purpose, among others, of diversifying his investment portfolio, exercising options and paying taxes.
- Shares of Common Stock were sold at a price ranging from a low of $21.65 per share to a high of $22.62.
- These options, which are fully vested and exercisable, represent a portion of the reporting person's 319,127 options originally granted under the 2005 Executive Stock Option Plan.